Differences

This shows you the differences between two versions of the page.

--- publications [2026/03/26 18:30]
ramirez [2026]
+++ publications [2026/04/01 09:21] (current)
ramirez [2025]
@@ Line 7: / Line 7: @@
 Martins ER, Forofontov M, Mota Freitas J, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]]. 2026. <fc #0000FF>Two //Streptococcus agalactiae// ST283 invasive infections in Portugal raise the possibility of the emergence of this unusual lineage in Europe</fc>. Front Microbiol 16: 1712362. [[https://www.ncbi.nlm.nih.gov/pubmed/41669694/|(PMID: 41669694)]].
+Boto CM, Raposo Carneiro S, Ramalho M, Passos Coelho I, Moitinho de Almeida I, Ferreira C, Tomé ML, Sousa Dias M, Araújo Carvalho A, Machado R, Oliveira M, Seruca M, Boto L, Prata F, Penteado R, Carmo A, Rodrigues F, Tavares M, Rebelo S, Ribeiro M, [[people:jfsilva|Gomes-Silva J]], [[people:afriaes|Friães A]], [[people:anacosta|Silva-Costa C]], [[people:ramirez|Ramirez M]], [[people:jmelocristino|Melo-Cristino J]], Pereira Lemos A, Gouveia C. 2025. <fc #0000FF>Increasingly frequent parapneumonic empyema by group A streptococcus is more severe than by //Streptococcus pneumoniae//</fc>. Pediatr Infect Dis J 45:312–316 [[https://www.ncbi.nlm.nih.gov/pubmed/41334964/|(PMID: 41334964)]].
 ===== 2025  =====
@@ Line 12: / Line 14: @@
 Mahomed SM, Hanscheid T, Almeida Y, Grobusch MP, Rebelo M. 2025. <fc #0000FF>Improving reproducibility of //Plasmodium falciparum// culture: a large-language-model-driven literature review and a parasite growth variability assessment of donor red blood cells</fc>. Malar J 25:46 [[https://www.ncbi.nlm.nih.gov/pubmed/41398683/|(PMID: 41398683)]].
-Boto CM, Raposo Carneiro S, Ramalho M, Passos Coelho I, Moitinho de Almeida I, Ferreira C, Tomé ML, Sousa Dias M, Araújo Carvalho A, Machado R, Oliveira M, Seruca M, Boto L, Prata F, Penteado R, Carmo A, Rodrigues F, Tavares M, Rebelo S, Ribeiro M, [[people:jfsilva|Gomes-Silva J]], [[people:afriaes|Friães A]], [[people:anacosta|Silva-Costa C]], [[people:ramirez|Ramirez M]], [[people:jmelocristino|Melo-Cristino J]], Pereira Lemos A, Gouveia C. 2025. <fc #0000FF>Increasingly frequent parapneumonic empyema by group A streptococcus is more severe than by //Streptococcus pneumoniae//</fc>. Pediatr Infect Dis J //In press// [[https://www.ncbi.nlm.nih.gov/pubmed/41334964/|(PMID: 41334964)]].
 van der Ende J, Bezemer JM, Hanscheid T, Grobusch MP, Trueba G. 2025. Amazon environment sharing featuring humans - dogs - capybaras and more. Adapting a one-health approach to leptospirosis prevention in indigenous riverine communities in Ecuador and beyond. New Microbes New Infect 68:101658 [[https://www.ncbi.nlm.nih.gov/pubmed/41278579/|(PMID: 41278579)]].
@@ Line 39: / Line 39: @@
 Stanley S, [[people:anacosta|Silva-Costa C]], [[people:jfsilva|Gomes-Silva J]], [[people:jmelocristino|Melo-Cristino J]], Malley R, [[people:ramirez|Ramirez M]]. 2025. <fc #0000FF>CC180 clade dynamics do not universally explain //Streptococcus pneumoniae// serotype 3 persistence post-vaccine: a global comparative population genomics study</fc>. Ebiomedicine 117:105781. [[https://www.ncbi.nlm.nih.gov/pubmed/40472804/|(PMID: 40472804)]]
-Carvalho BT, Meirinhos SV, Domingos GJ, Peixoto S, [[people:jmelocristino|Melo-Cristino J]]. 2025. <fc #0000FF>Unseen but unforgettable - refractive bacilli in the Gram stain of a muscular abscess</fc>. Eur J Clin Microbiol Infect Dis //In press// [[https://www.ncbi.nlm.nih.gov/pubmed/40307630/|(PMID: 40307630)]]
+Carvalho BT, Meirinhos SV, Domingos GJ, Peixoto S, [[people:jmelocristino|Melo-Cristino J]]. 2025. <fc #0000FF>Unseen but unforgettable - refractive bacilli in the Gram stain of a muscular abscess</fc>. Eur J Clin Microbiol Infect Dis 44:1749-1752 [[https://www.ncbi.nlm.nih.gov/pubmed/40307630/|(PMID: 40307630)]]
 Schnyder JL, de Jong HK, Bache EB, van Hest RM, Bélard S, Hanscheid T, Kremsner PG, Grobusch MP. 2025. <fc #0000FF>Which trial do we need? A randomised controlled study to compare the protective efficacy of early post-exposure discontinuation versus standard atovaquone-proguanil malaria prophylaxis in a human //Plasmodium falciparum// challenge model</fc>. Clin Microbiol Infect 31:1618–1622. [[https://www.ncbi.nlm.nih.gov/pubmed/40294866/|(PMID: 40294866)]]